|
|
||||||||
Original Research Communication |
1 From the Human Nutrition Laboratory, Swiss Federal Institute of Technology, Zürich, Switzerland (MBZ, CZ, and RFH); the Ministry of Health, Rabat, Morocco (NC and AS); and the Department of Endocrinology, University of Zürich Childrens Hospital, Zürich, Switzerland (TT).
Background: In many developing countries, children are at high risk of both goiter and iron deficiency anemia.
Objective: In a series of studies in northern Morocco, we developed and tested a dual-fortified salt (DFS) containing iodine and microencapsulated iron.
Design: To establish the DFS fortification concentration, we measured salt intake by 3-d weighed food records and estimated iron bioavailability from the local diet by using published algorithms. We then formulated a DFS containing 25 µg iodine/g salt (as potassium iodide) and 1 mg iron/g salt (as ferrous sulfate hydrate encapsulated with partially hydrogenated vegetable oil). After storage and acceptability trials, we compared the efficacy of the DFS to that of iodized salt in a 9-mo, randomized, double-blind trial in iodine-deficient, 615-y-old children (n = 377).
Results: Mean salt intake in school-age children was 712 g/d, and estimated iron bioavailability from the local diet was 0.44.3%. After storage for 20 wk, the DFS and iodized salt were not significantly different in iodine content, and color stability was acceptable when the compounds were added to local meals. During the efficacy trial, urinary iodine concentrations and thyroid volumes improved significantly (P < 0.001 and < 0.05, respectively) from baseline in both groups. At 40 wk, mean hemoglobin concentrations in the DFS group had increased by 14 g/L (P < 0.01), and serum ferritin, transferrin receptor, and zinc protoporphyrin concentrations were significantly better (P < 0.05) in the DFS group than in the iodized salt group. The prevalence of iron deficiency anemia in the DFS group decreased from 35% at baseline to 8% at 40 wk (P < 0.001).
Conclusion: A DFS containing iodine and encapsulated iron can be an effective fortification strategy.
Key Words: Iodine iron deficiency dual fortification salt anemia goiter hypothyroidism children Morocco
This article has been cited by other articles:
![]() |
J. L Varma, S. Das, R. Sankar, M. G V. Mannar, F J. Levinson, and D. H Hamer Community-level micronutrient fortification of a food supplement in India: a controlled trial in preschool children aged 36-66 mo Am. J. Clinical Nutrition, April 1, 2007; 85(4): 1127 - 1133. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Zimmermann, B. de Benoist, S. Corigliano, P. L. Jooste, L. Molinari, K. Moosa, E. A. Pretell, Z. S. Al-Dallal, Y. Wei, C. Zu-Pei, et al. Assessment of Iodine Status Using Dried Blood Spot Thyroglobulin: Development of Reference Material and Establishment of an International Reference Range in Iodine-Sufficient Children J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4881 - 4887. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Wegmuller, F. Camara, M. B. Zimmermann, P. Adou, and R. F. Hurrell Salt Dual-Fortified with Iodine and Micronized Ground Ferric Pyrophosphate Affects Iron Status but Not Hemoglobin in Children in Cote d'Ivoire J. Nutr., July 1, 2006; 136(7): 1814 - 1820. [Abstract] [Full Text] [PDF] |
||||
![]() |
American Academy of Pediatrics, S. R. Rose, and the Section on Endocrinology and Committee on, American Thyroid Association, R. S. Brown, and the Public Health Committee, and Lawson Wilkins Pediatric Endocrine Society Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics, June 1, 2006; 117(6): 2290 - 2303. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Allen New Approaches for Designing and Evaluating Food Fortification Programs J. Nutr., April 1, 2006; 136(4): 1055 - 1058. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Moretti, M. B Zimmermann, R. Wegmuller, T. Walczyk, C. Zeder, and R. F Hurrell Iron status and food matrix strongly affect the relative bioavailability of ferric pyrophosphate in humans Am. J. Clinical Nutrition, March 1, 2006; 83(3): 632 - 638. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B Zimmermann, P. Winichagoon, S. Gowachirapant, S. Y Hess, M. Harrington, V. Chavasit, S. R Lynch, and R. F Hurrell Comparison of the efficacy of wheat-based snacks fortified with ferrous sulfate, electrolytic iron, or hydrogen-reduced elemental iron: randomized, double-blind, controlled trial in Thai women Am. J. Clinical Nutrition, December 1, 2005; 82(6): 1276 - 1282. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Muller and M. Krawinkel Malnutrition and health in developing countries Can. Med. Assoc. J., August 2, 2005; 173(3): 279 - 286. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Mei, M. E. Cogswell, I. Parvanta, S. Lynch, J. L. Beard, R. J. Stoltzfus, and L. M. Grummer-Strawn Hemoglobin and Ferritin Are Currently the Most Efficient Indicators of Population Response to Iron Interventions: an Analysis of Nine Randomized Controlled Trials J. Nutr., August 1, 2005; 135(8): 1974 - 1980. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B Zimmermann, L. Molinari, F. Staubli-Asobayire, S. Y Hess, N. Chaouki, P. Adou, and R. F Hurrell Serum transferrin receptor and zinc protoporphyrin as indicators of iron status in African children Am. J. Clinical Nutrition, March 1, 2005; 81(3): 615 - 623. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B Zimmermann, N. Chaouki, and R. F Hurrell Iron deficiency due to consumption of a habitual diet low in bioavailable iron: a longitudinal cohort study in Moroccan children Am. J. Clinical Nutrition, January 1, 2005; 81(1): 115 - 121. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B Zimmermann, R. Wegmueller, C. Zeder, N. Chaouki, R. Biebinger, R. F Hurrell, and E. Windhab Triple fortification of salt with microcapsules of iodine, iron, and vitamin A Am. J. Clinical Nutrition, November 1, 2004; 80(5): 1283 - 1290. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Zimmermann, R. Wegmuller, C. Zeder, N. Chaouki, and T. Torresani The Effects of Vitamin A Deficiency and Vitamin A Supplementation on Thyroid Function in Goitrous Children J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5441 - 5447. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B Zimmermann, R. Wegmueller, C. Zeder, N. Chaouki, F. Rohner, M. Saissi, T. Torresani, and R. F Hurrell Dual fortification of salt with iodine and micronized ferric pyrophosphate: a randomized, double-blind, controlled trial Am. J. Clinical Nutrition, October 1, 2004; 80(4): 952 - 959. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Baltussen, C. Knai, and M. Sharan Iron Fortification and Iron Supplementation are Cost-Effective Interventions to Reduce Iron Deficiency in Four Subregions of the World J. Nutr., October 1, 2004; 134(10): 2678 - 2684. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B Zimmermann, R. Wegmuller, C. Zeder, T. Torresani, and N. Chaouki Rapid relapse of thyroid dysfunction and goiter in school-age children after discontinuation of salt iodization Am. J. Clinical Nutrition, April 1, 2004; 79(4): 642 - 645. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B Zimmermann, D. Moretti, N. Chaouki, and T. Torresani Development of a dried whole-blood spot thyroglobulin assay and its evaluation as an indicator of thyroid status in goitrous children receiving iodized salt Am. J. Clinical Nutrition, June 1, 2003; 77(6): 1453 - 1458. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |